Brain-derived neurotrophic factor in Huntington disease

Brain Research

Volumn 866, Issue 1-2, 2000, Pages 257-261

  Ferrer, I ^a,b   Goutan, E ^b   Marin C ^b   Rey, M J ^b   Ribalta, T ^b  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Brain derived neurotrophic factor; Huntington Disease; Neurodegeneration; Trophic factors

Indexed keywords

BRAIN DERIVED GROWTH FACTOR; QUINOLINIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BRAIN REGION; CELL GROWTH; CELL SURVIVAL; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; HUNTINGTON CHOREA; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TEMPORAL CORTEX; WESTERN BLOTTING;

AGED; BRAIN; BRAIN-DERIVED NEUROTROPHIC FACTOR; FEMALE; HUMANS; HUNTINGTON DISEASE; MALE; NEURONS;

EID: 0034595722     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(00)02237-X     Document Type: Article

References (32)

1. C.A. Altar, N. Cai, T. Bliven, M. Juhasz, J.M. Conner, A.L. Acheson, R.M. Lindsay, S.J. Wiegand, Anterograde transport of brain-derived neurotrophic factor and its role in the brain, Nature 389 (1997) 856-860.
2. M. Barbacid, Structural and functional properties of the Trk family of neurotrophin receptors, Ann. NY Acad. Sci. 766 (1995) 442-458.
3. S. Catsicas, D. Larhammar, A. Blomqvist, P.P. Sanna, R.J. Milner, M.C. Willson, Expression of a conserved cell-type specific protein in nerve terminals coincides with synaptogenesis, Proc. Natl. Acad. Sci. USA 88 (1991) 785-789.
4. B. Connor, D. Young, Q. Yan, R.L. Faull, B. Synek, M. Dragunow, Brain-derived neurotrophic factor is reduced in Alzheimer's disease, Mol. Brain Res. 49 (1997) 71-81.
5. M. Dragunow, R. Faull, P. Lawlor, E.J. Beilharz, K. Singleton, E.B. Walker, E. Mee, In situ evidence for DNA fragmentation in Huntington's disease striatum and Alzheimer's disease temporal lobes, NeuroReport 6 (1995) 1053-1057.
6. P. Ernphors, C.F. Ibañez, T. Ebendal, L. Olson, H. Person, Molecular cloning and neurotrophic activities of a protein with structural similarities to nerve growth factor: developmental and topographical expression in the brain, Proc. Natl. Acad. Sci. USA 87 (1990) 5454-5458.
7. I. Ferrer, Nuclear DNA fragmentation in Creutzfeldt-Jakob disease: does a mere positive in situ nuclear end-labeling indicate apoptosis?, Acta Neuropathol. 97 (1998) 5-12.
8. I. Ferrer, C. Marin, M.J. Rey, T. Ribalta, Brain-derived neurotrophic factor in frontotemporal dementia, Neurosci. Lett. 279 (1999) 33-36.
9. I. Ferrer, C. Marin, M.J. Rey, T. Ribalta, E. Goutan, R. Blanco, E. Tolosa, BDNF and full-length and truncated TrkB expression in Alzheimer's disease. Implications in therapeutic strategies, J. Neuropathol. Exp. Neurol. 58 (1999) 729-739.
10. D.T. Hess, T.M. Slater, M.C. Wilson, J.H.P. Skemne, The 25 kDa synaptosomal-associated protein SNAP-25 is the major methioninerich polypeptide in rapid axonal transport and a major substrate for palmitoylation in adult CNS, J. Neurosci. 12 (1992) 4634-4641.
11. D.C. Hilt, J.A. Miller, E. Malta, Early experiences with trophic factors as drugs for neurological diseases: brain-derived neurotrophic factor and ciliary neurotrophic factor in ALS, in: V.E. Koliatsos, R.R. Ratan (Eds.), Cell Death and Diseases of the Nervous System, Humana Press, Totowa, NJ, 1999, pp. 593-607.
12. K. Jellinger, Is there apoptosis in Lewy body disease?, Acta Neuropathol. 97 (1998) 413-415.
13. Y. Kawamoto, S. Nakamura, I. Akiguchi, J. Kimura, Immunohistochemical localization of brain-derived neurotrophic factor in the spinal cords of amyotrophic lateral sclerosis and non-amyotrophic lateral sclerosis patients, J. Neuropathol. Exp. Neurol. 57 (1998) 822-830.
14. V.E. Koliatsos, I. Mocchetti, Trophic factors as therapeutic agents for diseases characterized by neuronal death, in: V.E. Koliatsos, R.R. Ratan (Eds.), Cell Death and Diseases of the Nervous System, Humana Press, Totowa, NJ, 1999, pp. 545-591.
15. J. Leibrock, F. Lottspeich, A. Hohn, H. Hofer, B. Hengerer, P. Masiakowski, H. Thoenen, Y.A. Barde, Molecular cloning and expression of brain-derived neurotrophic factor, Nature 341 (1989) 149-152.
16. G.R. Lewin, Y.A. Barde, Physiology of the neurotrophins, Annu. Rev. Neurosci. 19 (1996) 289-317.
17. A. Martínez-Serrano, A. Bjorklund, Protection of the neostriatum against excitotoxic damage by neurotrophin-producing, genetically-modified neural stem cells, J. Neurosci. 16 (1996) 4604-4616.
18. K. Mizuno, J. Carnahan, H. Nawa, Brain-derived neurotrophic factor promotes differentiation of striatal GABAergic neurons, Devl. Biol. 165 (1994) 243-256.
19. K.D. Murray, C.M. Gall, E.G. Jones, P.J. Isackson, Differential regulation of brain-derived neurotrophic factor and type II calcium/calmodulin-dependent protein kinase messenger RNA expression in Alzheimer's disease, Neuroscience 60 (1994) 37-48.
20. K. Nakao, P. Brudin, K. Funa, O. Lindwall, P. Odin, Trophic and protective actions of brain-derived neurotrophic factor on striatal DARP-32-containing neurons in vitro, Devl. Brain Res. 90 (1995) 92-101.
21. M. Narisawa-Saito, K. Wakabayashi, S. Tsuji, H. Takahashi, H. Nawa, Regional specificity of alterations in NGF, BDNF and NT-3 levels in Alzheimer's disease, NeuroReport 7 (1996) 2925-2928.
22. E. Pérez-Navarro, J. Alberch, I. Neveu, E. Arenas, BDNF, NT-3, NT-4/5 differentially regulate the phenotype and prevent degenerative changes of striatal projection neurons after excitotoxicity in vivo, Neuroscience 91 (1999) 1257-1264.
23. H.S. Phillips, J.M. Hains, M. Armanini, G.R. Laramee, S.A. Johnson, J.M. Winslow, BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease, Neuron 7 (1991) 695-702.
24. C. Portera-Cailliou, J.C. Hedreen, D.L. Price, V.E. Koliatsos, Evidence of apoptotic cell death in Huntington disease and excitotoxic animal models, J. Neurosci. 15 (1995) 3775-3787.
25. A. Reiner, R.L. Albin, H.D. Anderson, C.J. D'Amato, J.B. Pentney, A.B. Young, Differential loss of striatal projection neurons in Huntington disease, Proc. Natl. Acad. Sci. USA 85 (1998) 5733-5737.
26. C.A. Ross, M.W. Becher, V.E. Koliatsos, Huntington's disease and DRPLA, in: V.E. Koliatsos, R.R. Ratan (Eds.), Cell Death and Diseases of the Nervous System, Humana Press, Totowa, NJ, 1999, pp. 477-496.
27. C. Stadelmann, W. Brück, C. Bancher, K. Jellinger, H. Lassman, Alzheimer disease: DNA fragmentation indicates increased nuclear vulnerability, but not apoptosis, J. Neuropathol. Exp. Neurol. 57 (1998) 456-464.
28. The Huntington's Disease Collaborative Research Group, A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes, Cell 72 (1993) 971-983.
29. L.B. Thomas, D.J. Gates, E.K. Richfield, T.F. O'Brian, J.B. Schweitzer, D.A. Steindler, DNA end-labeling (TUNEL) in Huntington's disease and other neuropathological conditions, Exp. Neurol. 133 (1995) 265-272.
30. R. Ventimiglia, P.E. Mather, B.E. Jones, R.M. Lindsay, The neurotrophins BDNF, NT-3 and NT-4/5 promote survival and morphological and biochemical differentiation of striatal neurons in vitro, Eur. J. Neurosci. 7 (1995) 213-222.
31. G.P.G. Vonsattel, M. DiFiglia, Huntington disease, J. Neuropathol. Exp. Neurol. 57 (1998) 369-384.
32. J.P. Vonsattel, R.H. Myers, T.J. Stevens, R.J. Ferrante, E.D. Bird, E.P. Richardson, Neuropathological classification of Huntington's disease, J. Neuropathol. Exp. Neurol. 4 (1985) 559-577.